Valuation (74%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 13.88 | N/A |
| PEG Ratio (TTM) | -9.95 | N/A |
| P/S Ratio (TTM) | 4.69 | N/A |
| P/B Ratio (TTM) | 1.71 | N/A |
| P/FCF Ratio (TTM) | 12.05 | N/A |
| Price to 5YR AVG Earnings Ratio | 15.17 | N/A |
| Price to 5YR AVG FCF Ratio | 13.34 | N/A |
Profitability (80%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 11.77% | N/A |
| ROE (TTM) | 12.10% | N/A |
| Net Profit Margin (TTM) | 34.62% | N/A |
| ROIC 5YR AVG | 28.28% | N/A |
Growth (20%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -0.96% | -2.85% | 0.84% |
| Revenue | -5.38% | 5.97% | 4.11% |
| Net Income | -2.07% | -3.45% | 0.41% |
| Cash Flow | -1.24% | 8.23% | 5.96% |
Health (72%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 29.59 | N/A |
| Quick Ratio (TTM) | 26.94 | N/A |
| D/E Ratio (TTM) | N/A | N/A |
| Interest Coverage (TTM) | 8.28 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 25.75 | N/A |
| LTL to 5YR AVG FCF | 0.02 | N/A |
| Shares Outstanding Growth 5YR AVG | -0.50% | N/A |